ID

14790

Descrizione

Study of SRN-927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02316509

collegamento

https://clinicaltrials.gov/show/NCT02316509

Keywords

versioni (1)
  1. 28/04/16 28/04/16 -
Caricato su

28 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT02316509

Inglese

Eligibility Breast Cancer NCT02316509

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven diagnosis of adenocarcinoma of the breast with evidence of either locally recurrent disease not amenable to resection or radiation therapy with curative intent, or metastatic disease, both progressing after at least 6 months of hormonal therapy for er+ breast cancer
Descrizione

Breast adenocarcinoma | Recurrent disease | Excision | Therapeutic radiology procedure | Neoplasm Metastasis | Hormone Therapy Estrogen receptor positive Breast Carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0858252
UMLS CUI [2]
C0277556
UMLS CUI [3]
C0728940
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0027627
UMLS CUI [6,1]
C0279025
UMLS CUI [6,2]
C0279754
UMLS CUI [6,3]
C0678222
er-positive, her2-negative
Descrizione

Estrogen receptor positive status [ER+] | Human epidermal growth factor 2 negative carcinoma of breast

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1719706
UMLS CUI [2]
C2316304
no prior treatment with arn-810 (allowed only during dose expansion stage)
Descrizione

Prior Therapy Selective Estrogen Receptor Degrader ARN-810

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C3827161
no more than 2 prior chemotherapies in the advanced or metastatic setting
Descrizione

prior chemotherapy for advanced disease | Prior Chemotherapy Neoplasm Metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278940
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0027627
at least 2 months must have elapsed from the use of tamoxifen
Descrizione

Tamoxifen

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0039286
at least 6 months must have elapsed from the use of fulvestrant
Descrizione

fulvestrant

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0935916
at least 2 weeks must have elapsed from the use of any other anti-cancer hormonal therapy
Descrizione

cancer treatment Hormone Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0279025
at least 3 weeks must have elapsed from the use of any chemotherapy
Descrizione

Chemotherapy Regimen

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
females, 18 years of age or older
Descrizione

Gender | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
postmenopausal status as defined by the protocol
Descrizione

Postmenopausal state

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232970
eastern cooperative oncology group (ecog) performance status </= 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ function
Descrizione

body system or organ function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
untreated or symptomatic brain metastases
Descrizione

Metastatic malignant neoplasm to brain

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
current treatment with any systemic anti-cancer therapies for advanced disease or any systemic experimental treatment on another clinical trial
Descrizione

Systemic cancer treatment Advanced disease | Therapies, Investigational

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0679246
UMLS CUI [2]
C0949266
any of the following within 12 months prior to enrollment: myocardial infarction, severe/unstable angina, ongoing cardiac dysrhythmias of grade >/= 2, atrial fibrillation of any grade, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, or cerebrovascular accident including transient ischemic attack
Descrizione

Myocardial Infarction | Angina Pectoris | Angina, Unstable | Cardiac Arrhythmia | Atrial Fibrillation | Coronary Artery Bypass Surgery | Congestive heart failure Symptomatic | Cerebrovascular accident | Transient Ischemic Attack

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002962
UMLS CUI [3]
C0002965
UMLS CUI [4]
C0003811
UMLS CUI [5]
C0004238
UMLS CUI [6]
C0010055
UMLS CUI [7,1]
C0018802
UMLS CUI [7,2]
C0231220
UMLS CUI [8]
C0038454
UMLS CUI [9]
C0007787
active inflammatory bowel disease or chronic diarrhea, short bowel syndrome, or upper gastrointestinal surgery including gastric resection
Descrizione

Inflammatory Bowel Diseases | Chronic diarrhea | Short Bowel Syndrome | Upper gastrointestinal surgery | Gastrectomy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0401151
UMLS CUI [3]
C0036992
UMLS CUI [4]
C1319412
UMLS CUI [5]
C0017118
known human immunodeficiency virus infection
Descrizione

HIV Infections

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
major surgery within 4 weeks prior to enrollment
Descrizione

major surgery

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679637
radiation therapy within 2 weeks prior to enrollment
Descrizione

radiation therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT02316509

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma | Recurrent disease | Excision | Therapeutic radiology procedure | Neoplasm Metastasis | Hormone Therapy Estrogen receptor positive Breast Carcinoma
Item
histologically or cytologically proven diagnosis of adenocarcinoma of the breast with evidence of either locally recurrent disease not amenable to resection or radiation therapy with curative intent, or metastatic disease, both progressing after at least 6 months of hormonal therapy for er+ breast cancer
boolean
C0858252 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0728940 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0027627 (UMLS CUI [5])
C0279025 (UMLS CUI [6,1])
C0279754 (UMLS CUI [6,2])
C0678222 (UMLS CUI [6,3])
Estrogen receptor positive status [ER+] | Human epidermal growth factor 2 negative carcinoma of breast
Item
er-positive, her2-negative
boolean
C1719706 (UMLS CUI [1])
C2316304 (UMLS CUI [2])
Prior Therapy Selective Estrogen Receptor Degrader ARN-810
Item
no prior treatment with arn-810 (allowed only during dose expansion stage)
boolean
C1514463 (UMLS CUI [1,1])
C3827161 (UMLS CUI [1,2])
prior chemotherapy for advanced disease | Prior Chemotherapy Neoplasm Metastasis
Item
no more than 2 prior chemotherapies in the advanced or metastatic setting
boolean
C0278940 (UMLS CUI [1])
C1514457 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Tamoxifen
Item
at least 2 months must have elapsed from the use of tamoxifen
boolean
C0039286 (UMLS CUI [1])
fulvestrant
Item
at least 6 months must have elapsed from the use of fulvestrant
boolean
C0935916 (UMLS CUI [1])
cancer treatment Hormone Therapy
Item
at least 2 weeks must have elapsed from the use of any other anti-cancer hormonal therapy
boolean
C0920425 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
Chemotherapy Regimen
Item
at least 3 weeks must have elapsed from the use of any chemotherapy
boolean
C0392920 (UMLS CUI [1])
Gender | Age
Item
females, 18 years of age or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Postmenopausal state
Item
postmenopausal status as defined by the protocol
boolean
C0232970 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status </= 2
boolean
C1520224 (UMLS CUI [1])
body system or organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Metastatic malignant neoplasm to brain
Item
untreated or symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
Systemic cancer treatment Advanced disease | Therapies, Investigational
Item
current treatment with any systemic anti-cancer therapies for advanced disease or any systemic experimental treatment on another clinical trial
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0679246 (UMLS CUI [1,3])
C0949266 (UMLS CUI [2])
Myocardial Infarction | Angina Pectoris | Angina, Unstable | Cardiac Arrhythmia | Atrial Fibrillation | Coronary Artery Bypass Surgery | Congestive heart failure Symptomatic | Cerebrovascular accident | Transient Ischemic Attack
Item
any of the following within 12 months prior to enrollment: myocardial infarction, severe/unstable angina, ongoing cardiac dysrhythmias of grade >/= 2, atrial fibrillation of any grade, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, or cerebrovascular accident including transient ischemic attack
boolean
C0027051 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
C0003811 (UMLS CUI [4])
C0004238 (UMLS CUI [5])
C0010055 (UMLS CUI [6])
C0018802 (UMLS CUI [7,1])
C0231220 (UMLS CUI [7,2])
C0038454 (UMLS CUI [8])
C0007787 (UMLS CUI [9])
Inflammatory Bowel Diseases | Chronic diarrhea | Short Bowel Syndrome | Upper gastrointestinal surgery | Gastrectomy
Item
active inflammatory bowel disease or chronic diarrhea, short bowel syndrome, or upper gastrointestinal surgery including gastric resection
boolean
C0021390 (UMLS CUI [1])
C0401151 (UMLS CUI [2])
C0036992 (UMLS CUI [3])
C1319412 (UMLS CUI [4])
C0017118 (UMLS CUI [5])
HIV Infections
Item
known human immunodeficiency virus infection
boolean
C0019693 (UMLS CUI [1])
major surgery
Item
major surgery within 4 weeks prior to enrollment
boolean
C0679637 (UMLS CUI [1])
radiation therapy
Item
radiation therapy within 2 weeks prior to enrollment
boolean
C1522449 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial